semaglutide patent india With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are Ozempic Patent Ends On March

It is also not the same thing as microdosing, a practice pushed by some influencers that involves taking less than the prescribed amount

But product quality is not always the issue

Innovative Treatments: The staff stays abreast of emerging treatment options, ensuring patients receive the most effective and current therapies available

How Mounjaro works Mounjaro mimics two hormones: Like Ozempic, it activates the GLP-1 receptor It also activates a second receptor called GIP (glucose-dependent insulinotropic polypeptide) This dual-action mechanism likely explains why Mounjaro produces greater weight loss and improvements in blood sugar in clinical trials